| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $14K | -91.0% |
| R&D Expense | $33.2M | +63.6% |
| SG&A Expense | $9.5M | -1.5% |
| Operating Income | -$42.6M | -43.4% |
| Interest Expense | $789K | -65.4% |
| Pre-tax Income | $42.1M | +40.2% |
| Net Income | -$42.1M | -40.2% |
| EPS (Basic) | -$2.11 | -26.3% |
| EPS (Diluted) | -$2.11 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.9M | -41.6% |
| Accounts Receivable | $1.2M | -38.0% |
| Current Assets | $22.7M | -43.3% |
| Total Assets | $39.6M | -30.6% |
| Current Liabilities | $7.2M | -60.9% |
| Long-term Debt | $15.0M | — |
| Total Liabilities | $7.5M | -60.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.4M | -178.5% |
| Financing Cash Flow | $18.2M | +531.0% |
| -26.3% |
| Stockholders' Equity |
| $32.1M |
| -14.0% |